WEST SACRAMENTO, CA – Raley’s Family of Fine Stores removed Raley’s Frozen Sweet Pumpkin Ravioli 10 oz.from our Raley’s, Bel Air and Nob Hill stores on November 17, 2015. According to the manufacturer, the product may contain an undeclared cashew and almond allergen.
Read The Complete Story!
FDA approves first seasonal influenza vaccine containing an adjuvant
The U.S. Food and Drug Administration today approved Fluad, the first seasonal influenza vaccine containing an adjuvant. Fluad, a trivalent vaccine produced from three influenza virus strains (two subtype A and one type B), is approved for the prevention of seasonal influenza in people 65 years of age and older.
FDA approves Portrazza to treat advanced squamous non-small cell lung cancer
The U.S. Food and Drug Administration today approved Portrazza (necitumumab) in combination with two forms of chemotherapy to treat patients with advanced (metastatic) squamous non-small cell lung cancer (NSCLC) who have not previously received medication specifically for treating their advanced lung cancer.
Mi Tienda Issues Precautionary Recall: Recall Affects Masa and Tostadas Purchased ONLY at Mi Tienda #1 Located at 1630 Spencer Highway, South Houston, TX
Mi Tienda, committed to high-quality products, is issuing a precautionary recall for masa and tostadas produced in-store and packed on Monday, November 16 and Tuesday, November 17 only at the Mi Tienda #1 store located at 1630 Spencer Highway, South Houston, TX. The precautionary recall is due to the possible presence of metal fragments in the Masa Preparada by the pound, Tostadas Botoneras Rojas and Tostadas Siveria Large Tostadas.
FDA approves vaccine for use after known or suspected anthrax exposure
The U.S. Food and Drug Administration today approved a new indication for BioThrax (Anthrax Vaccine Adsorbed) to prevent disease following suspected or confirmed exposure to Bacillus anthracis, the bacterium that causes anthrax disease. The vaccine’s new use is approved for people 18 through 65 years of age in conjunction with recommended antibiotic treatment. BioThrax was initially approved by the FDA in 1970 for the prevention of anthrax disease in persons at high risk of exposure.
FDA approves vaccine for use after known or suspected anthrax exposure
The U.S. Food and Drug Administration today approved a new indication for BioThrax (Anthrax Vaccine Adsorbed) to prevent disease following suspected or confirmed exposure to Bacillus anthracis, the bacterium that causes anthrax disease. The vaccine’s new use is approved for people 18 through 65 years of age in conjunction with recommended antibiotic treatment. BioThrax was initially approved by the FDA in 1970 for the prevention of anthrax disease in persons at high risk of exposure.
FDA approves Opdivo to treat advanced form of kidney cancer
The U.S. Food and Drug Administration today approved Opdivo (nivolumab) to treat patients with advanced (metastatic) renal cell carcinoma, a form of kidney cancer, who have received a certain type of prior therapy.
Casey’s Bakery Inc. Issues Allergy Alert On Undeclared Peanuts in Snickers 8×8 Cake
Casey’s Bakery Inc. of Sioux Center, Iowa is voluntarily recalling all Snickers 8×8 cakes produced prior November 14, 2015, because the cakes contain undeclared peanuts. People who have an allergy or severe sensitivity to peanuts run the risk of serious or life-threatening allergic reaction if they consume these products.
FDA approves Ninlaro, new oral medication to treat multiple myeloma
Today the U.S. Food and Drug Administration granted approval for Ninlaro (ixazomib) in combination with two other therapies to treat people with multiple myeloma who have received at least one prior therapy.
Fit Firm and Fabulous Issues Voluntary Nationwide Recall of Ultimate Herbal Slimcaps Due to the Presence of Undeclared Sibutramine
Fit Firm and Fabulous is voluntarily recalling lots 05/02/2015 to 05/01/2017 of Ultimate Herbal Slimcap capsules, to the consumer level. FDA analysis has found the product to contain undeclared sibutramine. Sibutramine was a previously approved controlled substance that was removed from the U.S. market in October 2010 for safety reasons.